Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.
about
Guidelines for the diagnosis and treatment of malignant pleural mesotheliomaLong-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.Imaging characteristics of pleural tumours.Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 casesDetermination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based methodImprovement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment.SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.Asbestos and the lung in the 21st century: an update.Relation between neutrophil/lymphocyte ratio and primary tumor metabolic activity in patients with malign pleural mesothelioma.
P2860
Q28394028-3C0A6025-FE76-4C35-AA24-2BFDA2299BE1Q33438674-791242FB-63CC-47D1-8C96-8F579C10C78BQ36307991-C5D160BA-A4D8-4A2C-9471-F386E5D7000CQ36411835-7675F480-3DAC-4E93-953E-6EA50C2AF360Q37261280-13D55B80-7294-41D2-84DC-1D17422C44A5Q37716864-D5D70BEF-9B92-4E13-83EF-77CF1111A6CCQ42332509-0D264ABF-AECB-470F-8D1F-32E07FCC6DA3Q50878255-7A00BCF3-C896-4D0C-8D70-0BD8FCFE63C9Q51428846-8EFFAC2B-1168-475F-AFCB-EA6369A6F7A3Q51757335-B80AC1BF-98FB-43FF-9C89-530392A39FC0
P2860
Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current evidence base of FDG-P ...... and global disease assessment.
@en
Current evidence base of FDG-P ...... and global disease assessment.
@nl
type
label
Current evidence base of FDG-P ...... and global disease assessment.
@en
Current evidence base of FDG-P ...... and global disease assessment.
@nl
prefLabel
Current evidence base of FDG-P ...... and global disease assessment.
@en
Current evidence base of FDG-P ...... and global disease assessment.
@nl
P2093
P2860
P1476
Current evidence base of FDG-P ...... and global disease assessment.
@en
P2093
Abass Alavi
Babak Saboury
Drew A Torigian
Sandip Basu
P2860
P2888
P304
P356
10.1007/S11307-010-0426-6
P577
2011-10-01T00:00:00Z